Serological screening of relatives of celiac disease patients: Antiendomysium antibodies, anti-tissue transglutaminase or both?;Triagem sorológica de familiares de pacientes com doença celíaca: Anticorpos anti-endomísio, antitransglutaminase ou ambos?

Arquivos de Gastroenterologia

Volumn 44, Issue 2, 2007, Pages 156-161

  Utiyama, Shirley Ramos Da Rosa ^a,c   Nass, Flávia Raphaela ^a   Kotze, Lorete Maria Da Silva ^b   Nisihara, Renato Mitsunori ^a   Ambrosio, Altair Rogério ^a   De Messias Reason, Iara Taborda ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b HOSPITAL UNIVERSITÁRIO CAJURU   (Brazil)

^c Laboratório de Imunopatologia   (Brazil)

Author keywords

Autoantibodies; Celiac disease; Family; Immunoglobulins; Serologic tests; Transglutaminases

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SCREENING; SEROLOGY; UMBILICAL CORD;

EID: 35648980019     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032007000200014     Document Type: Article

References (28)

1. Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428-35.
2. Bai J, Zeballos E, Fried M, Corazza GR, Schuppan D, Farthing MJG, Catassi C, Greco L, Cohen H, Krabshuis JH. Celiac disease. World J Gastroenterol. 2005;10 suppl:1-8.
3. Book L, Zone JJ, Neuhausen SL. Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol. 2003;98:377-81.
4. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of the tissue transglutaminase as the auto antigen of celiac disease. Nat Med. 1997;3:797-801.
5. Dolinsek J, Urlep D, Karell K, Partanen J, Micetic-Turk D. The prevalence of celiac disease among family members of celiac disease patients. Wien Klin Wochenschr. 2004;116 suppl 2:8-12.
6. Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garrity C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, Macneil J, Mack D, Patel D, Moher D. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128 (4 suppl 1):s57-s67.
7. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horwath K. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286-92.
8. Gudjonsdottir AH, Nilsson S, Ek J, Kristiansson B, Ascher H. The risk of celiac disease in 107 families with at least two affected siblings. J Pediatr Gastroenterol Nutr. 2004;38:338-42.
9. Hervonen K, Hakanen M, Kaukinen K, Collin P, Reunala T. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol. 2002;37:51-5.
10. Korponay-Szabo I, Kovacs J, Lorinez M, Torok E, Goracz G. Families with multiple cases of gluten-sensitive enteropathy. Z Gastroenterol. 1998;36:553-8.
11. Kotze LM, Utiyama SR, Nisihara RM, Zeni MP, Sena MG, Amarante HM. Antiendomysium antibodies in Brazilian patients with celiac disease and their first-degree relatives. Arq Gastroentol. 2001;38:94-103.
12. Kotze LM, Utiyama SR, Nisihara RM, de Camargo VF, Ioshii SO. IgA class anti-endomysial and anti-tissue transglutaminase antibodies in relation to duodenal mucosa changes in celiac disease. Pathology. 2003;35:56-60.
13. Kotze LM. Gynecologic and obstetric findings related to nutritional status and adherence to a gluten-free diet in Brazilian patients with celiac disease. J Clin Gastroenterol. 2004; 38:567-74.
14. a ed. São Paulo: Atheneu; 2005. p.703-24.
15. a ed. Rio de Janeiro: Guanabara Koogan; 2006. p.284-316.
16. Kotze LMS, Nisihara RM, Utiyama SRR, Piovezan GC, Kotze LR. Thyroid disorders in Brazilian patients with celiac disease. J Clin Gastroenterol. 2006;40:33-6.
17. Miller A, Paspaliaris W, Elliott PR, d'Apice A. Antitransglutaminase antibodies and celiac disease. Aust N Z J Med. 1999;29:239-42.
18. Mustalahti K, Lohiniemi S, Collin P, Vuolteenaho N, Laippala P, Maki M. Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract. 2002;5:105-13.
19. Nisihara RM, Utiyama SR, Kotze LM. Prevalência da doença celíaca na região sul do Brasil. In: V Semana Brasileira do Aparelho Digestivo, 2002; Rio de Janeiro, Brasil: Anais da V Semana Brasileira do Aparelho Digestivo; 2002. p.19-20.
20. Nisihara RM, Kotze LM, Utiyama SR, Oliveira NP, Fieldler PT, Messias-Reason IT. Celiac disease in children and adolescents with Down syndrome. J Pediatr (Rio J). 2005;81:373-6.
21. Palacios SM, Rivero MA, Sanchez VVF, Feijoo BE, Ramos AM, Oliveira OJ, Garcia MS. The tissue transglutaminase antibody: usefulness in the diagnosis of celiac disease objective. An Esp Pediatr. 2000;53:542-6.
22. Reeves GE, Burns C, Hall ST, Gleeson M, Lemmert K, Clancy RL. The measureament of IgA and IgG transglutaminase antibodies in celiac disease: a comparison with current diagnostic methods. Pathology. 2000;32:181-5.
23. Sjoberg K, Carlsson A. Screening for celiac disease can be justified in high-risk groups. Lakartidningen. 2004;101:3912, 3915-6, 3918-9.
24. Sugai E, Selvaggio G, Vazquez H, Viola M, Mazure R, Pizarro B, Smecuol E, Flores D, Pedreira S, Maurino E, Gomez JC, Bai JC. Tissue transglutaminase antibodies in celiac disease: assessment of a commercial kit. Am J Gastroenterol. 2000;95:2318-22.
25. Utiyama SR, Kotze LM, Nisihara RM, Carvalho RF, Carvalho EG, Sena MG, Reason IJTM. Spectrum of autoantibodies in celiac patients and relatives. Dig Dis Sci. 2001;46:2624-30.
26. Utiyama SRR, Kotze LMS, Nisihara RM, de Camargo VF. Correlaç ão dos anticorpos anti-endomísio e antitransglutaminase com a doença celíaca. Rev Bras Anal Clin. 2002;34:39-45.
27. Utiyama SRR, Kotze LMS, Reason ITM. Complement factor B allotypes in the susceptibility and severity of celiac disease in patients and relatives. Int J Immunogenet. 2005;32:307-14.
28. Volta U, Molinaro M, de Franceschi L, Fratangelo D, Bianchi FB. IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening. Save both money and monkeys. Dig Dis Sci. 1995;40:1902-5.